| Net income | -40.34M |
| Depreciation and amortization | 4.92M |
| Loss on disposal of assets | 126K |
| Stock-based compensation | 1.08M |
| Realized gain on investments | |
| Deferred tax assets | -554K |
| Excess tax benefits from stock-based compensation | |
| Accounts receivable | -240K |
| Inventories | 5.07M |
| Other inventory supplies | 638K |
| Prepaid expenses and other current assets | 1.64M |
| Accounts payable | -1.05M |
| Accrued payroll | 1.27M |
| Corporate income and franchise taxes | |
| Advanced payments | 457K |
| Accrued and other current liabilities | -891K |
| Net cash provided by operating activities | |
| Purchases of property and equipment | -595K |
| Purchases of investments | -24K |
| Proceeds from sale of investments | 8.92M |
| Net cash (used in) investing activities | |
| Proceeds from issuance of common stock, net of issuance costs of $4,063 | |
| Proceeds from exercise of options | 0 |
| Restricted cash | -6K |
| Excess tax benefits from stock-based compensation | |
| Net cash provided by financing activities | |
| Net effect of currency translation | -355K |
| Net increase in cash and cash equivalents | -4.85M |
| Cash and cash equivalents, beginning of period | 21.22M |
| Cash and cash equivalents, end of period | 16.37M |
| Supplemental disclosures of cash flow information Cash paid for income taxes | |
| Supplemental disclosures of non-cash transactions Unrealized loss on investments | |